Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00622557 · ClinicalTrials.gov registry record
General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)
A clinical trial of Ulcerative Colitis and Crohn's Disease, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 200,000
- Enrollment target
- 1
- Study location
NCT00622557: Completed study of Ulcerative Colitis and Crohn's Disease, sponsored by University Hospitals Cleveland Medical Center.
NCT00622557 is a study of Ulcerative Colitis and Crohn's Disease that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 200,000 participants, above the 418-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (47747% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00622557, a study of Ulcerative Colitis and Crohn's Disease, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 200,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A database has been established to track the outcomes of all cases performed in the University Hospitals Department of Surgery in an effort to improve quality of surgical performance and case management. Specifically, the purpose of the database will be used as a quality improvement tool for analyzing process and outcome measures and to accurately track cases performed by surgeons.
Conditions Studied
Study Locations (1)
Ohio
- University Hospitals Case Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2007-05-01 |
| Est. Completion | 2017-01-06 |
What the finished NCT00622557 record still lists
NCT00622557 is an observational study that tracks outcomes without assigning an intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus, above the 418-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (47747% higher).
The record links to 6 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 0 interventions.
NCT00622557 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00622557 about?
NCT00622557 is a clinical study titled "General Surgical Outcomes Quality Improvement Database (UH-SOCRATES)". A database has been established to track the outcomes of all cases performed in the University Hospitals Department of Surgery in an effort to improve quality of surgical performance and case management. Specifically, the purpose of the database will be used as a quality improvement tool for analyz...
What is the current status of trial NCT00622557?
This trial is currently completed. The enrollment target is 200,000 participants. The study started on 2007-05-01. Estimated completion is 2017-01-06.
What conditions does trial NCT00622557 study?
This clinical trial studies the following conditions: Ulcerative Colitis, Crohn's Disease, Colon Cancer, Rectal Cancer, Diverticulitis.
Who is sponsoring clinical trial NCT00622557?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00622557 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00622557's enrollment target sits among peer trials
200,000 1st of 122 higher than 122 of 122 other Ulcerative Colitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ulcerative Colitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI